A review on newly approved PARP inhibitors: Talazoparib and Olaparib

A review on newly approved PARP inhibitors: Talazoparib and Olaparib

This project report is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.

Dettagli Bibliografici
Autore principale:	Karim, Azrin
Altri autori:	Islam, Farzana
Natura:	Project report
Lingua:	English
Pubblicazione:	Brac University 2024
Soggetti:	PARP inhibitors Olaparib Talazoparib DNA damage repair DDR signaling pathway Homologous recombination repair Prostate cancer Ovarian cancer Metastatic breast cancer BRCA mutations Cancer > Treatment > Genetic aspects. DNA repair. NAD-ADP-ribosyltransferase > Inhibitors > Therapeutic use. Antineoplastic agents.
Accesso online:	http://hdl.handle.net/10361/24372

Documenti analoghi

A review on potential of PARP inhibitors in the treatment of prostate cancer
di: Islam, Saidul
Pubblicazione: (2022)

Association of XRCC1 and XPD polymorphism with risk of prostate cancer in Bangladesh population
di: Ahmed, Nafisa
Pubblicazione: (2023)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
di: Meem, Manila
Pubblicazione: (2023)

RIPK pathway, as a potential target, for cancer treatment - a review
di: Jahan, Nusrat
Pubblicazione: (2024)

Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies
di: Alam, Tahera
Pubblicazione: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
di: Flora, Sanzida Alam
Pubblicazione: (2024)

Mutation in DNA polymerase γ: mitochondrial disorders
di: Hossain, Sadman Sanjid
Pubblicazione: (2023)

Immunotherapy in the Management of Lung Cancer
di: Tasnim, Humayra
Pubblicazione: (2022)

Statistics and informatics in molecular cancer research

Association of BRCA1, BRCA2, RAD51, and HER2 gene polymorphisms with the breast cancer risk in the Bangladeshi population
di: Parvin, Salma, et al.
Pubblicazione: (2016)

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
di: Khan, Muidul Hasan
Pubblicazione: (2024)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
di: Mirza, Maisa Tasnim
Pubblicazione: (2023)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
di: Ratu, Tabassum
Pubblicazione: (2024)

Association of MTHFR rs1801133, PEMT rs4244593, CHKA rs7928739, VNTRs IL-1RN intron 2 and NOS3 intron 4 polymorphisms with unexplained intrauterine fetal death in Bangladeshi population
di: Mahasin, Deera, et al.
Pubblicazione: (2024)

Cancer risk factors: a critical review
di: Tabassum, Tahsina
Pubblicazione: (2017)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
di: Nawar, Anika
Pubblicazione: (2019)

Repurposing Albendazole and Mebendazole, an antiparasitic drug in treating colorectal cancer- a review
di: Mondal, Shawon
Pubblicazione: (2023)

Repairing & maintaining yard equipment & power tools /
di: Schultz, Mort J.
Pubblicazione: (1994)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
di: Abir, Shifaty Nur
Pubblicazione: (2024)

Targeting BRAFV600E in the treatment of CRC
di: Roja, Mashwiyat Samrin
Pubblicazione: (2024)

Role of statins as antagonists of SPARC in gastric cancer
di: Shahmat, Rad
Pubblicazione: (2019)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
di: Pial, Sazia Afrin
Pubblicazione: (2018)

A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
di: Sorno, Rubina Haque
Pubblicazione: (2024)

A review on the role of histone deacetylase SIRT6 in high-grade serous ovarian Cancer
di: Rahman, Tazin
Pubblicazione: (2022)

Epigenetic therapy in cancer
di: Abid, Md. Shadman Ridwan
Pubblicazione: (2021)

Current practice and approaches of immunotherapy in Cancer treatment
di: Khondokar, Faiza
Pubblicazione: (2022)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
di: Rahman, Sanjida
Pubblicazione: (2024)

Recent advances in Cancer treatment targeting autophagy and future aspects
di: Emon, Kamrul Hasan
Pubblicazione: (2022)

Biosimilar in lymphoma treatment
di: Tanisha, Mehrin Haque
Pubblicazione: (2021)

Molecules associated with the development of lung cancer
di: Rahman, Adree, et al.
Pubblicazione: (2023)

Current perspectives on cancer prevention strategies: implications for Bangladesh
di: Afrin, Sajia
Pubblicazione: (2017)

Evaluation of genetics of cancer predisposition in patients and efficacy of various chemotherapeutic drugs in Bangladesh
di: Hossain, Safa Binte
Pubblicazione: (2019)

Potential of nanoparticles as a topical drug delivery system for skin cancer: a review
di: Islam, Karima
Pubblicazione: (2022)

ক্যান্সার : মৃত্যু অবধারিত নয় /
di: করীম, আবুল বাশার মোহাম্মদ ফজলুল

Point-of care diagnostic devices in cancer detection
di: Yasmin, Rizwana
Pubblicazione: (2022)

Breast cancer awareness seminars
di: Anwer Khan Modern Medical College
Pubblicazione: (2016)

Protein biomarkers for Lung Cancer: a bioinformatic approach
di: Jeba, Joynob
Pubblicazione: (2017)

Current scenario of Cancer in Dhaka City, Bangladesh
di: Natth, Bratakatha
Pubblicazione: (2016)

Molecular biology of cancer : mechanisms, targets, and therapeutics /
di: Pecorino, Lauren
Pubblicazione: (2012)

A comprehensive review on drug repurposing in cancer treatment
di: Sarkar, Onusree
Pubblicazione: (2024)